http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
최근 10년간 천식환자에서 흡입 스테로이드제 처방 빈도와 중증 악화 빈도의추세 분석
노창석 ( Chang Suk Noh ),이재승 ( Jae Seung Lee ),송진우 ( Jin Woo Song ),김태범 ( Tae Bum Kim ),김남국 ( Nam Kug Kim ),조유숙 ( You Sook Cho ),이상도 ( Sang Do Lee ),문희범 ( Hee Bom Moon ),오연목 ( Yeon Mok Oh ) 대한결핵 및 호흡기학회 2011 Tuberculosis and Respiratory Diseases Vol.70 No.5
Background: Inhaled corticosteroids (CSs) are the most essential medication for asthma control. Many reports suggest that the usage of ICSs improves not only the control of asthma symptoms but also prevents exacerbation. We investigated whether increases in ICS prescriptions are associated with decreases in asthma exacerbation in the clinical practice setting. Methods: We retrospectively analyzed the database of adult asthma patients who had visited a tertiary referral hospital, the Asan Medical Center between January 2000 and December 2009. The number of emergency department (ED) visits, admissions, intensive care unit (ICU) care, deaths, and ICS prescriptions were analyzed to evaluate the time trend of asthma exacerbation as a function of the ICS prescription rate during the ten years. Results: The numbers of ED visits, admissions, and episodes of ICU care decreased during the ten years (p<0.001, p=0.033, p=0.001, respectively) while the number of ICS prescriptions increased (p<0.001). We found a correlation between the number of ICS prescriptions and the number of ED visits, admissions, or ICU care. For these outcomes, the correlation coefficients were r=-0.952, p<0.001; r=-0.673, p=0.033; r=-0.948, p<0.001, respectively. Conclusion: The number of ICS prescriptions increased during the past ten years while the number of asthma exacerbations decreased. Our results also showed a negative correlation between the ICS prescription rate and asthma exacerbation in the clinical practice setting. In other words, an increase in ICS prescription may be a major cause of a decrease in asthma exacerbations.
만성 폐쇄성 폐질환의 의료이용 현황 및 관련 요인: 전국조사를 통한 1990년에서 2008년까지 변화추이
이기동 ( Gi Dong Lee ),도세록 ( Se Rok Doh ),이재승 ( Jae Seung Lee ),노창석 ( Chang Suk Noh ),이상도 ( Sang Do Lee ),김동순 ( Dong Soon Kim ),오연목 ( Yeon Mok Oh ) 대한결핵 및 호흡기학회 2011 Tuberculosis and Respiratory Diseases Vol.70 No.4
Background: Chronic obstructive pulmonary disease (COPD) is a major cause of death and disability worldwide and one of the most prevalent diseases in Korea. We examined trends and risk factors of health care utilization for COPD in Korea. Methods: We retrospectively analyzed the database of Patient Surveys from 1990 through 2008, which were nationwide surveys of health services utilization through outpatient department (OPD) visits and hospitalization. Physician-diagnosed COPD patients whose ages were 45 years and older were included. Results: OPD visits and hospitalization of COPD patients between 1990 and 2008 were estimated to be 68,552 and 17,774 persons, respectively. Trends in OPD visits and hospitalization for COPD significantly increased from 1990 through 2008 (p=0.019, p=0.001, respectively). The increment rate for OPD visits was 2.0 fold over those years; for hospitalization it was 3.3 fold. Risk factors for OPD visits for COPD were male gender (odd ration [OR], 1.41; 95% confidence interval [CI], 1.39∼1.43), those aged 65 years and older (OR, 1.50; 95% CI, 1.47∼1.53), residential area other than a metropolis (OR, 1.08; 95% CI, 1.07∼1.010) and access to a physician`s office (OR, 1.17; 95% CI, 1.14∼1.21). Risk factors for hospitalization were male gender (OR, 2.15; 95% CI, 2.07∼2.23), those aged 65 year and older (OR, 2.86; 95% CI, 2.72∼3.00), residential area other than a metropolis (OR, 1.98; 95% CI, 1.90∼2.07) and access to a hospital (OR, 2.88; 95% CI, 2.59∼3.22) (p<0.001, both). Conclusion: Health care utilization for COPD subjects increased from 1990 to 2008. Risk factors for the utilization were male gender, older age, and residential area other than a metropolis.
전원 온 환자의 의료기관별 호흡기 검체에서의 균 종류 비교
김태형,조경표,이재성,우용문,성지석,노창석 이화여자대학교 의과학연구소 2013 EMJ (Ewha medical journal) Vol.36 No.2
Objectives: Since the 1990s, drug-resistant bacteria have become common pathogens of hospital-acquired infections. In recent years, healthcare-associated infections have come to the fore, and it is reported that distribution rates of these bacteria are comparable to those of hospital-acquired infections. However, there have been few studies on differences in resistant bacteria depending on the size of hospitals. Thus, the authors studied differences in drug-resistant bacteria between a tertiary hospital and smaller medical institutions. Methods: We retrospectively analyzed the clinical findings and sputum culture results of patients transferred from tertiary hospitals (group A, n=74) and those transferred from smaller medical institutions (group B, n=65). Results: The number of patients with malignancy was higher in group A than in group B. The length of intensive care unit stay was longer in group A than in group B. Antibiotic therapy and mechanical ventilation were more frequently used in group A than in group B. There were no significant differences between the 2 groups in bacterial species (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa) and their resistance rates to carbapenem, while there were significant differences between the 2 groups in the bacterial species (Acinetobacter baumannii) and its resistance rate to carbapenem. Conclusion: In this study, there were significant differences between the 2 groups in the bacterial species and resistance rates to carbapenem for A. baumannii infection unlike other bacterial infections. Further studies on risk factors and patient classification are needed to confirm our results.